F12‐46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema

Publisher： John Wiley & Sons Inc

E-ISSN： 1398-9995|70|12|1661-1664

ISSN： 0105-4538

Source： ALLERGY, Vol.70, Iss.12, 2015-12, pp. : 1661-1664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hereditary angioedema with normal C1‐INH with versus without specific F12 gene mutations

By  

ALLERGY, Vol. 70, Iss. 8, 2015-08 ,pp. : 1004-1012

John Wiley & Sons Inc

Access to resources Recommend Favorite

Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema

By  

International Archives of Allergy and Immunology, Vol. 166, Iss. 4, 2015-04 ,pp. : 259-266

Karger

Access to resources Recommend Favorite

Long-Term Prophylaxis of Hereditary Angioedema with a Pasteurized C1 Inhibitor Concentrate

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 4, 2010-10 ,pp. : 356-359

Karger

Access to resources Recommend Favorite

Hereditary Angioedema in Greece: The First Results of the Greek Hereditary Angioedema Registry

By  

International Archives of Allergy and Immunology, Vol. 164, Iss. 4, 2014-09 ,pp. : 326-332

Karger

Access to resources Recommend Favorite

Hereditary angioedema with a mutation in the plasminogen gene

By  

ALLERGY, Vol. 73, Iss. 2, 2018-02 ,pp. : 442-450

John Wiley & Sons Inc

Access to resources Recommend Favorite